Cormedix Inc.
Pharmaceutical ManufacturingView the employees at
Cormedix Inc.-
Chuck Wagner Vice President, Market Access at Cormedix Inc.
-
New York City Metropolitan Area
-
Rising Star
Antony Pfaffle Chief Scientific Officer at CORMEDIX INC.-
Potwin, Kansas, United States
-
Rising Star
-
New York City Metropolitan Area
-
Rising Star
Liz Hurlburt Executive Vice President, Head of Clinical and Medical Affairs at CorMedix-
Simsbury, Connecticut, United States
-
Top 5%
Patty West-Thielke Experienced, results driven professional offering expertise in KOL engagement, clinical trial development and execution, and pharmacology with extensive experience in immunology, transplant nephrology and rare disease.-
Greater Chicago Area
-
Rising Star
Overview
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is focused on developing its lead product DefenCath™, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need. For more information, visit: www.cormedix.com.
-